Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 28;17(9):1857–1870. doi: 10.1002/1878-0261.13472

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 2 — Kaplan–Meier survival estimates according to ctDNA detection. (A) Progression‐free survival (PFS) according to baseline ctDNA detection (Baseline ctDNA + or −). (B) Overall survival (OS) according to baseline ctDNA detection (Baseline ctDNA + or −). (C) PFS according to ctDNA detection after 1 month of chemotherapy (1 month ctDNA + or −). (D) OS according to ctDNA detection after 1 month of chemotherapy (1 month ctDNA + or −). One patient experienced disease progression before the second sample collection, and was therefore only included in the analysis of OS (D). Censored patients are indicated by plus symbols (+) on the survival estimate curves. P‐values correspond to log‐rank tests for survival differences.